{"nct_id":"NCT03029143","title":"Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis","status":"COMPLETED","status_verified_date":"2023-07","start_date":"2017-03-29","start_date_type":"ACTUAL","primary_completion_date":"2020-10-16","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-16","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["TAK"]}